• Károly Fäller, AstraZeneca, Hungary, Clinical Research Director, Bulgaria, Israel, Romania
  • Vesta Marciulioniene, Pfizer, Lithuania, Head Clinical Operations
  • Ivan Mihaylov, Sanofi, Bulgaria, Medical and Regulatory Head
  • Lucia Turcan, The Medicines Agency of Moldova, Head of Drug Evaluation-Authorization Department
  • Tamás Paál, GYEMSZI, National Institute of Pharmacy, Hungary,Senior Adviser; Professor, Institute of Drug Regulatory Affairs, University of Szeged
  • Marek Migdal, Children‘s Memorial Health Institute Poland, Head of Paediatric Intensive Care Unit; Member, Paediatric Committee, EMEA
  • Jean-Pierre Tassignon, Belgium Former Chairman, European Forum for Good Clinical Practices Member, Belgian College of Pharmaceutical Medicine
  • Jolanta Bilińska, Patient Safety Foundation, Poland, Chairman Memeber, International Alliance of Patients Organizations
  • Judit Koranyi, Baxter Innovations, Austria, Director, Global Clinical Operations, Established Products
  • Svitlana Pustovit, Ukrainian Association on Bioethics, President
  • Alexandru Ionel, Novartis, Romania, CSO
  • Victor Dmitriev, Associations of the Russian Pharmaceuticals Manufacturers, Russia, General Director
  • József Kovács, Semmelweis University of Medicine, Russia, Head Department of Bioethics, Institute of Behavioral Studies
  • Johannes Pleiner, Medical University Vienna, Vienna School of Clinical Research, Austria, Associate Professor; Board Member
  • Dmitry Orishchenko, Eli Lilly, Russia, Clinical Development Team Leader, Neuroscience and Autoimmune Disorders
  • Olga I. Kubar, St. Petersburg Pasteur Institute, Russia, Head of Clinical Department, Vice Chair IBC UNESCO
  • Judit Tarnai, Hungarian Clinical Trial Management Society, Hungary, Country Manager and Clinical Operations Director of Pharm-Olam Medical Research Ltd.
  • Eva Bistáková, GSK, Slovakia, Clinical Research Manager

PANEL OF EXPERT ADVISORS

  • Hans Hoogkamer, Actelion, Switzerland, Senior Director, Business and Science Affairs
  • Ramil Abdrachitov, AstraZeneca, Russia, Clinical Research Director, Russia and Ukraine
  • Olga I. Kubar, Russia, Head of Clinical Department, St. Petersburg Pasteur Institute; Vice Chair, International Bioethics Committee, UNESCO Honorary Member, FECCIS
  • Ivan Mihaylov, Sanofi, Bulgaria, Medical and Regulatory Head
  • Barbara-Valenta Singer, Baxter, Austria, Senior Director, Global Clinical Operations
  • Mikhail Putilovskiy, Materia Medica Holding, Russia, Deputy Director, Head of Clinical Research Department